| scholarly article | Q13442814 |
| P50 | author | Jean-Christophe Leveque | Q39032922 |
| P2093 | author name string | R L Huganir | |
| A Barczak | |||
| A Rajadhyaksha | |||
| C Konradi | |||
| S Kang | |||
| W Macías | |||
| X M Li | |||
| J T Coyle | |||
| S Heckers | |||
| R R Carlson | |||
| P2860 | cites work | Regulation of NMDA receptors by an associated phosphatase-kinase signaling complex | Q22010193 |
| Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine | Q24319813 | ||
| Loss of haloperidol induced gene expression and catalepsy in protein kinase A-deficient mice | Q24645188 | ||
| Regulation of NMDA receptor phosphorylation by alternative splicing of the C-terminal domain | Q28259857 | ||
| Striatal N-methyl-D-aspartate receptors in haloperidol-induced catalepsy | Q28323154 | ||
| Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects | Q28327576 | ||
| Mice with reduced NMDA receptor expression display behaviors related to schizophrenia | Q28510751 | ||
| Cloned glutamate receptors | Q29619950 | ||
| L-Type Ca(2+) channels are essential for glutamate-mediated CREB phosphorylation and c-fos gene expression in striatal neurons | Q34377561 | ||
| Molecular components of striatal plasticity: the various routes of cyclic AMP pathways | Q34383634 | ||
| The cAMP-response-element-binding protein interacts, but Fos protein does not interact, with the proenkephalin enhancer in rat striatum | Q36445408 | ||
| Differential expression of c-fos and zif268 in rat striatum after haloperidol, clozapine, and amphetamine | Q37000403 | ||
| Dopamine receptor gene expression by enkephalin neurons in rat forebrain. | Q37662769 | ||
| Haloperidol-induced Fos expression in striatum is dependent upon transcription factor cyclic AMP response element binding protein | Q38297164 | ||
| Modulation of striatal enkephalinergic neurons by antipsychotic drugs. | Q39806881 | ||
| Glutamate receptor phosphorylation and synaptic plasticity. | Q40628117 | ||
| Proteins bound at adjacent DNA elements act synergistically to regulate human proenkephalin cAMP inducible transcription | Q41094949 | ||
| Regulated subcellular distribution of the NR1 subunit of the NMDA receptor | Q41294276 | ||
| NMDA receptor antagonists inhibit catalepsy induced by either dopamine D1 or D2 receptor antagonists | Q42288365 | ||
| Quantitative light microscopic demonstration of increased pallidal and striatal met5-enkephalin-like immunoreactivity in rats following chronic treatment with haloperidol but not with clozapine: implications for the pathogenesis of neuroleptic-induc | Q42461559 | ||
| MK 801 reverses haloperidol-induced catalepsy from both striatal and extrastriatal sites in the rat brain | Q42547817 | ||
| p1B15: a cDNA clone of the rat mRNA encoding cyclophilin | Q42656764 | ||
| The NMDA receptor antagonist MK-801 markedly reduces the induction of c-fos gene by haloperidol in the mouse striatum. | Q48265063 | ||
| New insights into how antipsychotic drugs might work | Q48286423 | ||
| Protein kinase C reduces Mg2+ block of NMDA-receptor channels as a mechanism of modulation | Q48493712 | ||
| Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine | Q48594909 | ||
| Intracellular cAMP regulates the response to NMDA in hippocampal neurons | Q48636029 | ||
| Cyclic AMP-dependent protein kinase and protein kinase C phosphorylate N-methyl-D-aspartate receptors at different sites | Q48708894 | ||
| Characterization of protein kinase A and protein kinase C phosphorylation of the N-methyl-D-aspartate receptor NR1 subunit using phosphorylation site-specific antibodies | Q48797328 | ||
| Competitive antagonists and partial agonists at the glycine modulatory site of the mouse N-methyl-D-aspartate receptor | Q48874861 | ||
| Atypical and typical neuroleptic treatments induce distinct programs of transcription factor expression in the striatum | Q48892221 | ||
| Beta-adrenergic regulation of synaptic NMDA receptors by cAMP-dependent protein kinase | Q49133448 | ||
| Tardive dyskinesia and substrates of energy metabolism in CSF. | Q52012185 | ||
| Calcium influx via the NMDA receptor induces immediate early gene transcription by a MAP kinase/ERK-dependent mechanism. | Q52046731 | ||
| Glutamate agonist activity: implications for antipsychotic drug action and schizophrenia. | Q52204121 | ||
| Analysis of the proenkephalin second messenger-inducible enhancer in rat striatal cultures. | Q52206344 | ||
| Regulation of NMDA receptors by tyrosine kinases and phosphatases | Q57083922 | ||
| D-cycloserine added to clozapine for patients with schizophrenia | Q57131290 | ||
| Glycine potentiates the NMDA response in cultured mouse brain neurons | Q59050531 | ||
| A cyclic AMP- and phorbol ester-inducible DNA element | Q59069805 | ||
| D2 dopamine receptor antagonists induce fos and related proteins in rat striatal neurons | Q60513771 | ||
| Isolation of RNA | Q69127628 | ||
| A DNA cassette containing a trimerized SV40 polyadenylation signal which efficiently blocks spurious plasmid-initiated transcription | Q69365150 | ||
| Involvement of adenosine and glutamate receptors in the induction of c-fos in the striatum by haloperidol | Q71570016 | ||
| Dose-finding trial of D-cycloserine added to neuroleptics for negative symptoms in schizophrenia | Q71933595 | ||
| An overview of the mechanism of action of clozapine | Q72808224 | ||
| Effects of chronic haloperidol and clozapine treatment on neurotensin and c-fos mRNA in rat neostriatal subregions | Q72818406 | ||
| Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity | Q72818475 | ||
| A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia | Q77805002 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 4011-4020 | |
| P577 | publication date | 2000-06-01 | |
| P1433 | published in | Journal of Neuroscience | Q1709864 |
| P1476 | title | Intracellular modulation of NMDA receptor function by antipsychotic drugs | |
| P478 | volume | 20 |
| Q35760215 | Abnormal activity of the MAPK- and cAMP-associated signaling pathways in frontal cortical areas in postmortem brain in schizophrenia |
| Q44489637 | Acute ethanol affects phosphorylation state of the NMDA receptor complex: implication of tyrosine phosphatases and protein kinase A. |
| Q44063801 | Altered expression and phosphorylation of N-methyl-D-aspartate receptors in piglet striatum after hypoxia-ischemia |
| Q34383654 | Antipsychotic drugs and neuroplasticity: insights into the treatment and neurobiology of schizophrenia |
| Q42539139 | Antipsychotic drugs elevate mRNA levels of presynaptic proteins in the frontal cortex of the rat. |
| Q30386608 | Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection |
| Q35598785 | Behavioural and molecular endophenotypes in psychotic disorders reveal heritable abnormalities in glutamatergic neurotransmission. |
| Q44403878 | Calcium-dependent, D2 receptor-independent induction of c-fos by haloperidol in dopamine neurons. |
| Q64246237 | Chronic Antipsychotic Treatment Modulates Aromatase (CYP19A1) Expression in the Male Rat Brain |
| Q40226041 | Clozapine functions through the prefrontal cortex serotonin 1A receptor to heighten neuronal activity via calmodulin kinase II-NMDA receptor interactions. |
| Q92403507 | Clozapine in Treatment-Resistant Bipolar Disorder With Suicidality. Three Case Reports |
| Q44508155 | Clozapine inhibits isolated N-methyl-D-aspartate receptors expressed in xenopus oocytes in a subunit specific manner |
| Q48126033 | Clozapine upregulates the expression of the vesicular GABA transporter (VGAT) in rat frontal cortex |
| Q37394262 | Cocaine effects on dopamine and NMDA receptors interactions in the striatum of Fischer rats |
| Q44824836 | Cocaine's long run. |
| Q58693044 | Current Concepts and Treatments of Schizophrenia |
| Q44770086 | Decreased phosphorylation of NMDA receptor type 1 at serine 897 in brains of patients with Schizophrenia. |
| Q73258728 | Degree of immediate early gene induction in striatum by eticlopride determines sensitivity to N-methyl-D-aspartate receptor blockade |
| Q37322477 | Developmental regulation of the NMDA receptor subunits, NR3A and NR1, in human prefrontal cortex. |
| Q46587048 | Differential effects of clozapine and haloperidol on interval timing in the supraseconds range |
| Q34372253 | Dopamine D1 receptors mediate CREB phosphorylation via phosphorylation of the NMDA receptor at Ser897-NR1. |
| Q34372135 | Dopamine D2-like antagonists induce chromatin remodeling in striatal neurons through cyclic AMP-protein kinase A and NMDA receptor signaling |
| Q34383670 | Dopamine-dependent increases in phosphorylation of cAMP response element binding protein (CREB) during precipitated morphine withdrawal in primary cultures of rat striatum |
| Q37405204 | Dopaminergic synapses in the caudate of subjects with schizophrenia: relationship to treatment response |
| Q35129718 | Effect of paliperidone and risperidone on extracellular glutamate in the prefrontal cortex of rats exposed to prenatal immune activation or MK-801. |
| Q44345714 | Effects of clozapine, haloperidol and iloperidone on neurotransmission and synaptic plasticity in prefrontal cortex and their accumulation in brain tissue: an in vitro study |
| Q34085866 | Existing and novel biological therapeutics in suicide prevention |
| Q33846961 | Expression of the NR2B-NMDA receptor trafficking complex in prefrontal cortex from a group of elderly patients with schizophrenia. |
| Q28299852 | GLT-1 upregulation impairs prepulse inhibition of the startle reflex in adult rats |
| Q36756365 | Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions |
| Q34837403 | Glutamatergic dysbalance and oxidative stress in in vivo and in vitro models of psychosis based on chronic NMDA receptor antagonism |
| Q24555193 | Glutamatergic modulation of hyperactivity in mice lacking the dopamine transporter |
| Q44612080 | Haloperidol impairs auditory filial imprinting and modulates monoaminergic neurotransmission in an imprinting‐relevant forebrain area of the domestic chick |
| Q33638853 | Hyperdopaminergic tone erodes prefrontal long-term potential via a D2 receptor-operated protein phosphatase gate |
| Q48284591 | Increased expression of c-Jun transcription factor in cerebellar vermis of patients with schizophrenia |
| Q34804420 | Integrative role for serotonergic and glutamatergic receptor mechanisms in the action of NMDA antagonists: potential relationships to antipsychotic drug actions on NMDA antagonist responsiveness |
| Q43833748 | Interaction between metabotropic and NMDA subtypes of glutamate receptors in sprout suppression at young synapses. |
| Q34372233 | L-type Ca2+ channel blockers promote Ca2+ accumulation when dopamine receptors are activated in striatal neurons |
| Q45242739 | Local glutamate receptor antagonism in the rat prefrontal cortex disrupts response inhibition in a visuospatial attentional task |
| Q43807495 | Long-term behavioral and neurodegenerative effects of perinatal phencyclidine administration: implications for schizophrenia |
| Q34094008 | Maladaptive striatal plasticity in L-DOPA-induced dyskinesia |
| Q22241430 | Mechanism of Action of Atypical Antipsychotic Drugs and the Neurobiology of Schizophrenia |
| Q41157725 | Metabotropic glutamate receptors: potential drug targets for psychiatric disorders |
| Q30428213 | Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment |
| Q89313952 | Molecular targets of atypical antipsychotics: From mechanism of action to clinical differences |
| Q57478268 | Multi-Target Approach for Drug Discovery against Schizophrenia |
| Q49160543 | N-Methyl-D-aspartate receptors and p38 mitogen-activated protein kinase are required for cAMP-dependent cyclase response element binding protein and Elk-1 phosphorylation in the striatum |
| Q36068372 | N-Methyl-D-aspartate receptors as a target for improved antipsychotic agents: novel insights and clinical perspectives |
| Q36756356 | Neurobiology of dopamine in schizophrenia |
| Q24632801 | Neurotensin-deficient mice show altered responses to antipsychotic drugs |
| Q44519012 | Opposite regulation by typical and atypical anti-psychotics of ERK1/2, CREB and Elk-1 phosphorylation in mouse dorsal striatum |
| Q24646484 | Posttranscriptional regulation of BK channel splice variant stability by miR-9 underlies neuroadaptation to alcohol |
| Q43260119 | Prenatal exposure to phencyclidine produces abnormal behaviour and NMDA receptor expression in postpubertal mice |
| Q44406470 | Protein kinase c is involved in clozapine’s facilitation of n-methyl-d-aspartate- and electrically evoked responses in pyramidal cells of the medial prefrontal cortex |
| Q35146132 | Schizophrenia: from phenomenology to neurobiology |
| Q42955171 | Striatal proenkephalin gene induction: coordinated regulation by cyclic AMP and calcium pathways |
| Q44464095 | Synapse-associated protein 90/postsynaptic density-95-associated protein (SAPAP) is expressed differentially in phencyclidine-treated rats and is increased in the nucleus accumbens of patients with schizophrenia |
| Q42506977 | The expression of glutamate transporter GLT-1 in the rat cerebral cortex is down-regulated by the antipsychotic drug clozapine |
| Q42446435 | The glycine transporter type 1 inhibitor N-[3-(4'-fluorophenyl)-3-(4'-phenylphenoxy)propyl]sarcosine potentiates NMDA receptor-mediated responses in vivo and produces an antipsychotic profile in rodent behavior. |
| Q37135618 | The relationship between duration of initial alcohol exposure and persistence of molecular tolerance is markedly nonlinear |
| Q44426998 | The striopallidal pathway is involved in antiparkinsonian-like effects of the blockade of group I metabotropic glutamate receptors in rats. |
| Q24682931 | The suppression of brain cold-stable microtubules in mice induces synaptic defects associated with neuroleptic-sensitive behavioral disorders |
| Q44645818 | The transcription factor NGFI-B (Nur77) and retinoids play a critical role in acute neuroleptic-induced extrapyramidal effect and striatal neuropeptide gene expression. |
| Q30981438 | Time-dependent changes in gene expression profiles of midbrain dopamine neurons following haloperidol administration. |
Search more.